The physics of atoms and the technology behind treating disease might sound like disparate fields. However, in the past few decades, advances in artificial intelligence, sensing, simulation and more have driven enormous impacts within the biotech industry.
A new study by the IBM Institute for Business Value found that surveyed CEOs are facing workforce, culture and governance challenges as they act quickly to implement and scale generative AI across their organizations.
Tech Mahindra, a leading global provider of technology consulting and digital solutions to enterprises across industries, announced they are collaborating with IBM (NYSE: IBM) to help businesses worldwide responsibly accelerate the adoption of generative AI (GenAI). TechM amplifAI0->∞, Tech Mahindra’s suite of AI offerings and solutions, can integrate with the IBM watsonx AI and data platform with AI Assistants to bring new GenAI and governance capabilities to enterprises.
IBM announced the availability of IBM Copilot Runway, a new offering from IBM Consulting designed to help enterprises create, customize, deploy and manage copilots including Copilot for Microsoft 365.
Tech Mahindra and IBM to Help Enterprises Accelerate Adoption of Trustworthy Generative AI Using watsonx
